| Nome |
# |
|
6MWT performance correlates with peripheral neuropathy but not with cardiac involvement in patients with hereditary transthyretin amyloidosis (hATTR), file de3e52b1-fbf1-762d-e053-3705fe0a30e0
|
184
|
|
Transthyretin-Related Familial Amyloid Polyneuropathy (TTR-FAP): A Single-Center Experience in Sicily, an Italian Endemic Area, file de3e52b0-639c-762d-e053-3705fe0a30e0
|
73
|
|
Advances in Treatment of ATTRv Amyloidosis: State of the Art and Future Prospects, file de3e52b3-bb8e-762d-e053-3705fe0a30e0
|
72
|
|
Sport activity in Charcot-Marie-Tooth disease: A case study of a Paralympic swimmer, file de3e52b0-4dc6-762d-e053-3705fe0a30e0
|
34
|
|
Parenteral nutrition improves nutritional status, autonomic symptoms and quality of life in transthyretin amyloid polyneuropathy, file de3e52b0-42fd-762d-e053-3705fe0a30e0
|
28
|
|
Serial scanning with 99mTc-3, 3-diphosphono-1, 2-propanodicarboxylic acid (99mTc-DPD) for early detection of cardiac amyloid deposition and prediction of clinical worsening in subjects carrying a transthyretin gene mutation, file de3e52b3-187e-762d-e053-3705fe0a30e0
|
18
|
|
TBK1 is associated with ALS and ALS-FTD in Sardinian patients, file de3e52b0-6289-762d-e053-3705fe0a30e0
|
17
|
|
Comparative analysis of C9orf72 and sporadic disease in a large multicenter ALS population: the effect of male sex on survival of C9orf72 positive patients., file de3e52b2-7d21-762d-e053-3705fe0a30e0
|
15
|
|
Evaluation of the psychometric properties of the EORTC chemotherapy-induced peripheral neuropathy questionnaire (QLQ-CIPN20), file de3e52b3-5ea7-762d-e053-3705fe0a30e0
|
14
|
|
Responsiveness of clinical outcome measures in Charcot-Marie-Tooth disease, file de3e52b0-7c7c-762d-e053-3705fe0a30e0
|
10
|
|
Subcutaneous immunoglobulin in CIDP and MMN: a different long-term clinical response?, file de3e52b0-5e9f-762d-e053-3705fe0a30e0
|
9
|
|
Rasch-Transformed Total Neuropathy Score clinical version (RT-TNSc©) in patients with chemotherapy-induced peripheral neuropathy, file de3e52b2-8dd8-762d-e053-3705fe0a30e0
|
9
|
|
Description of a large cohort of Caucasian patients with V122I ATTRv amyloidosis: neurological and cardiological features, file de3e52b3-8b3c-762d-e053-3705fe0a30e0
|
9
|
|
Charcot-Marie-Tooth 2F: phenotypic presentation of the Arg136Leu HSP27 mutation in a multigenerational family, file de3e52af-778d-762d-e053-3705fe0a30e0
|
7
|
|
Monitoring effectiveness and safety of Tafamidis in transthyretin amyloidosis in Italy: a longitudinal multicenter study in a non-endemic area, file de3e52b0-6b11-762d-e053-3705fe0a30e0
|
7
|
|
Genetic neuromuscular disorders: living the era of a therapeutic revolution. Part 1: peripheral neuropathies, file de3e52b2-9ec3-762d-e053-3705fe0a30e0
|
7
|
|
Charcot-Marie-Tooth disease: experience from a large Italian tertiary neuromuscular center, file de3e52b2-ef82-762d-e053-3705fe0a30e0
|
7
|
|
Evaluation of the psychometric properties of the EORTC chemotherapy-induced peripheral neuropathy questionnaire (QLQ-CIPN20), file de3e52b3-a737-762d-e053-3705fe0a30e0
|
7
|
|
Left atrial function in cardiac amyloidosis, file de3e52b0-6730-762d-e053-3705fe0a30e0
|
6
|
|
Are novel outcome measures for Charcot–Marie–Tooth disease sensitive to change? The 6-minute walk test and StepWatch™ Activity Monitor in a 12-month longitudinal study, file de3e52b2-fe10-762d-e053-3705fe0a30e0
|
6
|
|
Contactin 1, a Potential New Antigen Target in Membranous Nephropathy: A Case Report, file de3e52b5-605f-762d-e053-3705fe0a30e0
|
5
|
|
Expression of transglutaminase 2 does not differentiate focal myositis from generalized inflammatory myopathies, file de3e52ae-b142-762d-e053-3705fe0a30e0
|
4
|
|
Cardiovascular diseases may play a negative role in the prognosis of amyotrophic lateral sclerosis, file de3e52b3-b0e7-762d-e053-3705fe0a30e0
|
4
|
|
Use of Drugs for ATTRv Amyloidosis in the Real World: How Therapy Is Changing Survival in a Non-Endemic Area, file de3e52b4-f7e0-762d-e053-3705fe0a30e0
|
4
|
|
Flavocoxid counteracts muscle necrosis and improves functional properties in mdx mice: a comparison study with methylprednisolone, file de3e52ae-bf76-762d-e053-3705fe0a30e0
|
3
|
|
The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings, file de3e52ae-e5fd-762d-e053-3705fe0a30e0
|
3
|
|
Comparison Between 99mTc-Diphosphonate Imaging and MRI With Late Gadolinium Enhancement in Evaluating Cardiac Involvement in Patients With Transthyretin Familial Amyloid Polyneuropathy, file de3e52ae-e630-762d-e053-3705fe0a30e0
|
3
|
|
null, file de3e52b0-579a-762d-e053-3705fe0a30e0
|
3
|
|
Effects of teriparatide on bone mineral density and quality of life in Duchenne muscular dystrophy related osteoporosis: a case report, file de3e52b0-6aa9-762d-e053-3705fe0a30e0
|
3
|
|
Novel outcome measures for Charcot-Marie-Tooth disease: Validation and reliability of the 6-min walk test and StepWatch™ Activity Monitor and identification of the walking features related to higher quality of life, file de3e52b2-b824-762d-e053-3705fe0a30e0
|
3
|
|
null, file de3e52b2-ef86-762d-e053-3705fe0a30e0
|
3
|
|
The role of metacognitive beliefs on anxiety and depression among Amyotrophic Lateral Sclerosis caregivers, file de3e52b3-1c1f-762d-e053-3705fe0a30e0
|
3
|
|
Long-term treatment with subcutaneous immunoglobulin in multifocal motor neuropathy, file de3e52b4-d326-762d-e053-3705fe0a30e0
|
3
|
|
Patisiran in hATTR Amyloidosis: Six-Month Latency Period before Efficacy, file de3e52b4-f5c5-762d-e053-3705fe0a30e0
|
3
|
|
null, file de3e52ae-eb85-762d-e053-3705fe0a30e0
|
2
|
|
Etanercept for psoriasis and psoriatic arthritis in a patient with Charcot-Marie-Tooth disease., file de3e52b0-52d9-762d-e053-3705fe0a30e0
|
2
|
|
Facial onset sensory motor neuronopathy: not always a slowly progressive disorder., file de3e52b0-dfd6-762d-e053-3705fe0a30e0
|
2
|
|
Phenotypic variability of TTR Val122Ile mutation: a Caucasian patient with axonal neuropathy and normal heart, file de3e52b2-9c5e-762d-e053-3705fe0a30e0
|
2
|
|
Intrathecal administration of Nusinersen in type 1 SMA: successful psychological program in a single Italian center, file de3e52b2-b5b4-762d-e053-3705fe0a30e0
|
2
|
|
ATTRv amyloidosis Italian Registry: clinical and epidemiological data, file de3e52b3-100d-762d-e053-3705fe0a30e0
|
2
|
|
Circulating microRNAs Profile in Patients With Transthyretin Variant Amyloidosis, file de3e52b3-129c-762d-e053-3705fe0a30e0
|
2
|
|
null, file de3e52b3-21bc-762d-e053-3705fe0a30e0
|
2
|
|
The Role of NLRP3 Inflammasome in the Pathogenesis of Traumatic Brain Injury, file de3e52b3-893e-762d-e053-3705fe0a30e0
|
2
|
|
Factors predicting survival in ALS: a multicenter Italian study, file de3e52b4-6c91-762d-e053-3705fe0a30e0
|
2
|
|
Bilateral paramedian thalamic infarct after occlusion of the artery of Percheron, file de3e52ae-d1f5-762d-e053-3705fe0a30e0
|
1
|
|
Etanercept for psoriasis and psoriatic arthritis in a patient with Charcot-Marie-Tooth disease, file de3e52b0-4ee6-762d-e053-3705fe0a30e0
|
1
|
|
Variable phenotypes are associated with PMP22 missense mutations., file de3e52b2-5d19-762d-e053-3705fe0a30e0
|
1
|
|
Subcutaneous immunoglobulin in CIDP and MMN: a short-term nationwide study, file de3e52b3-21ba-762d-e053-3705fe0a30e0
|
1
|
|
Which are the factors influencing NIV adaptation and tolerance in ALS patients?, file de3e52b3-33ff-762d-e053-3705fe0a30e0
|
1
|
|
Long-term treatment with subcutaneous immunoglobulin in patients with chronic inflammatory demyelinating polyradiculoneuropathy: a follow-up period up to 7 years, file de3e52b3-389a-762d-e053-3705fe0a30e0
|
1
|
|
null, file de3e52b3-4b9f-762d-e053-3705fe0a30e0
|
1
|
|
The 6-min walk test as a new outcome measure in Amyotrophic lateral sclerosis, file de3e52b3-7202-762d-e053-3705fe0a30e0
|
1
|
|
Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study, file de3e52b3-76b2-762d-e053-3705fe0a30e0
|
1
|
|
From a misdiagnosis of anorexia nervosa to a dramatic patisiran-induced improvement in a patient with ATTRE89Q amyloidosis, file de3e52b3-bcc1-762d-e053-3705fe0a30e0
|
1
|
|
hATTR Pathology: Nerve Biopsy Results from Italian Referral Centers, file de3e52b3-d637-762d-e053-3705fe0a30e0
|
1
|
|
Rare among rare: Phenotypes of uncommon CMT genotypes, file de3e52b5-7f5b-762d-e053-3705fe0a30e0
|
1
|
| Totale |
618 |